OHI Omega Healthcare Investors Inc

Completed $240 Million in New Investments Year-to-Date

Repaid a $400 Million Debt Maturity in April

Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2024.

FIRST QUARTER 2024 AND RECENT HIGHLIGHTS

• Net income for the quarter of $69 million, or $0.27 per common share, compared to $37 million, or $0.15 per common share, for Q1 2023.
• Nareit Funds From Operations (“Nareit FFO”) for the quarter of $153 million, or $0.60 per common share, on 257 million weighted-average common shares outstanding, compared to $146 million, or $0.60 per common share, on 243 million weighted-average common shares outstanding, for Q1 2023.
• Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of $176 million, or $0.68 per common share, compared to $160 million, or $0.66 per common share, for Q1 2023.
• Funds Available for Distribution (“FAD”) for the quarter of $168 million, or $0.65 per common share, compared to FAD of $147 million, or $0.60 per common share, for Q1 2023.
• Completed $75 million in Q1 new investments consisting of $41 million in real estate loans, $13 million in real estate acquisitions and $21 million in capital renovation and construction projects.
• Issued 1 million common shares for gross proceeds of $33 million.
• Repaid $42 million in HUD mortgage loans related to expected facility transitions.
• Sold four facilities for $10 million in cash proceeds.
• Repaid $400 million of senior unsecured notes on April 1, 2024.
• Completed $165 million in new investments in Q2 2024 to date.

Nareit FFO, AFFO and FAD are supplemental non-GAAP financial measures that the Company believes are useful in evaluating the performance of real estate investment trusts (“REITs”). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.

CEO COMMENTS

Taylor Pickett, Omega’s Chief Executive Officer, stated, “Our first quarter financial performance exceeded our expectations on higher-than-expected interest income, as well as earlier-than-anticipated cash payments received related to a turnaround asset. At the same time, operating fundamentals continue to improve, with both occupancy and agency labor usage trending favorably, resulting in 1Q standalone EBITDAR coverage, excluding stimulus, of 1.42x. Additionally, the acquisition pipeline remains solid, and our balance sheet is well positioned to meet our accretive future capital allocation efforts.”

Mr. Pickett continued, “In April, we transitioned the remaining facilities from the Guardian portfolio to a new operator and have now completed this restructuring. In the first quarter, LaVie continued to pay in line with the prior period, while we work on completing this restructuring, and Maplewood cash payments were consistent with our expectations. As we have noted previously, as the year progresses and these restructurings are concluded, we would expect incremental cash payments from both these portfolios.”

Mr. Pickett concluded, “We were disappointed with the recently announced final ruling around minimum staffing. At a time when labor capacity is the biggest issue facing most facilities, we believe this rule will place an undue and unnecessary burden on the industry. Thankfully, with most of these requirements scheduled to start in a few years, the industry has time to address these onerous commitments.”

FIRST QUARTER 2024 RESULTS

Revenues – Revenues for the quarter ended March 31, 2024 totaled $243.3 million, an increase of $25.1 million over the same period in 2023. The increase primarily resulted from (i) the timing and impact of operator restructurings and transitions and (ii) revenue from new investments completed throughout 2023 and 2024. The increase was partially offset by a decrease in revenue from asset sales completed throughout 2023 and 2024.

Expenses – Expenses for the quarter ended March 31, 2024 totaled $174.1 million, a decrease of $25.8 million over the same period in 2023. The decrease primarily resulted from (i) a decrease in impairment on real estate properties, (ii) a decrease in depreciation and amortization expense and (iii) a decrease in interest expense, partially offset by (i) an increase in provision (recovery) for credit losses, (ii) an increase in acquisition, merger and transition related costs and (iii) an increase in stock-based compensation expense.

Other Income and Expense – Other income for the quarter ended March 31, 2024 totaled $2.6 million, a decrease of $13.7 million over the same period in 2023. The decrease primarily resulted from (i) an increase in (loss) gain on assets sold and (ii) an increase in loss on debt extinguishment, partially offset by an increase in other income – net.

Net Income – Net income for the quarter ended March 31, 2024 totaled $69.3 million, an increase of $32.5 million over the same period in 2023. The net increase primarily resulted from the aforementioned (i) $25.8 million decrease in total expenses, (ii) $25.1 million increase in total revenue, (iii) $13.7 million decrease in other income and expense, and also a $3.9 million increase in income tax (expense) benefit.

2024 FIRST QUARTER PORTFOLIO AND RECENT ACTIVITY

Operator Updates:

LaVie – In the first quarter of 2024, the Company sold two facilities that were leased to LaVie Care Centers, LLC (“LaVie”) for $7.7 million and transitioned two facilities that were leased to LaVie to another operator. In the first quarter of 2024, LaVie paid $4.4 million in rent. In April 2024, LaVie paid Omega approximately $1.5 million in rent.

Maplewood – In the first quarter of 2024, Maplewood Senior Living (“Maplewood”) paid $11.3 million in rent. In April 2024, Maplewood paid $3.8 million in rent.

Guardian – Guardian Healthcare (“Guardian”) failed to make its first quarter contractual rent payments. The Company recorded $0.1 million in revenue with the application of the balance of Guardian’s security deposit. In April 2024, the Company transitioned the remaining six Guardian facilities to a new operator for minimum initial contractual rent of $5.5 million per annum with the potential to increase contractual rent up to $12.4 million dependent on revenue received by the operator.

New Investments:

The following table presents investment activity for the three months ended March 31, 2024:

 

 

 

 

 

 

 

 

 

Three Months Ended

Investment Activity ($000’s)

 

March 31, 2024

 

 

$ Amount

 

%

Real property

 

$

13,269

 

17.7

%

Construction-in-progress

 

 

14,788

 

19.7

%

Capital expenditures

 

 

5,664

 

7.6

%

Real estate loans receivable

 

 

41,241

 

55.0

%

Total

 

$

74,962

 

100.0

%

$13 Million of Real Estate Acquisitions – In two separate first quarter transactions, the Company acquired two facilities for aggregate consideration of $13.3 million and leased them to an existing U.S. operator and U.K. operator. The facilities have a weighted average initial annual cash yield of 9.8%, with 2.5% annual escalators.

$41 Million in Real Estate Loans – In four separate first quarter transactions, the Company funded $41.2 million in mortgage and other real estate loans. The loans have a weighted-average interest rate of 9.6% with maturity dates ranging from January 31, 2027 through March 1, 2029.

$165 Million in Q2 2024 Investments – In the second quarter of 2024, the Company closed on $165.4 million in new investments, comprised of:

$72 Million in Loans – In May 2024, the Company funded $71.7 million in real estate loans to an existing U.K. operator, bearing a weighted average interest rate of 10.0%.

$63 Million Real Estate Acquisition – In May 2024, the Company acquired 32 facilities in the U.K. for aggregate consideration of $62.7 million and leased them to one new operator. The facilities have an initial annual cash yield of 10.0% with escalators of 2.5%.

$31 Million Real Estate Acquisition – In April 2024, the Company acquired a facility in Michigan for consideration of $31.0 million and leased it to an existing operator. The facility has an initial annual cash yield of 11.5% with annual escalators of 2.0%.

Asset Sales and Impairments:

$10 Million in Asset Sales – In the first quarter of 2024, the Company sold four facilities for $10.1 million in cash, recognizing a loss of $1.4 million.

Impairments and Assets Held for Sale – During the first quarter of 2024, the Company recorded a $5.3 million net impairment charge to reduce the net book value of three facilities to their estimated fair value.

As of March 31, 2024, the Company had 16 facilities classified as assets held for sale, totaling $81.5 million in net book value.

OPERATOR COVERAGE DATA

The following tables present operator revenue mix, census and coverage data based on information provided by the Company’s operators for the indicated periods. The Company has not independently verified this information, and it is providing this data for informational purposes only.

 

 

 

 

 

 

 

 

Operator Revenue Mix (1)

 

 

 

Medicare /

Private /

 

 

Medicaid

Insurance

Other

Three-months ended December 31, 2023

 

55.3

%

28.0

%

16.7

%

Three-months ended September 30, 2023

 

55.5

%

28.0

%

16.5

%

Three-months ended June 30, 2023

 

54.0

%

30.0

%

16.0

%

Three-months ended March 31, 2023

 

53.0

%

31.8

%

15.2

%

Three-months ended December 31, 2022

 

54.3

%

31.4

%

14.3

%

(1)

Excludes all facilities considered non-core and does not include federal stimulus revenue. For non-core definition, see First Quarter 2024 Financial Supplemental posted in the “Quarterly Supplements” section of Omega’s website.

 

 

 

 

 

 

 

 

 

 

Coverage Data

 

 

 

Before

After

 

 

Occupancy (2)

Management

Management

Operator Census and Coverage (1)

 

 

Fees (3)

Fees (4)

Twelve-months ended December 31, 2023

 

79.6

%

1.69x

1.33x

Twelve-months ended September 30, 2023

 

79.1

%

1.63x

1.28x

Twelve-months ended June 30, 2023

 

78.6

%

1.50x

1.15x

Twelve-months ended March 31, 2023

 

78.0

%

1.44x

1.10x

Twelve-months ended December 31, 2022

 

77.0

%

1.38x

1.04x

(1)

Excludes facilities considered non-core.

(2)

Based on available (operating) beds.

(3)

Represents EBITDARM of our operators, defined as earnings before interest, taxes, depreciation, amortization, Rent costs and management fees for the applicable period, divided by the total Rent payable to the Company by its operators during such period. “Rent” refers to the total monthly contractual rent and mortgage interest due under the Company’s lease and mortgage agreements over the applicable period.

(4)

Represents EBITDAR of our operators, defined as earnings before interest, taxes, depreciation, amortization, and Rent (as defined in footnote 3) expense for the applicable period, divided by the total Rent payable to the Company by its operators during such period. Assumes a management fee of 4%.

FINANCING ACTIVITIES

ATM Program and Dividend Reinvestment and Common Stock Purchase Plan – The following is a summary of the common shares issued in the first quarter of 2024:

 

 

 

 

 

 

 

 

 

 

 

Dividend

 

 

 

 

Reinvestment and

 

 

At-the-Market

 

Common Stock

 

 

Program

 

Purchase Plan

 

 

Q1 2024

 

 

 

 

 

 

 

Number of shares (000’s)

 

 

1,041

 

 

29

Average price per share

 

$

31.02

 

$

30.44

Gross proceeds ($000’s)

 

$

32,295

 

$

882

$42 Million in HUD Mortgage Payoffs – In the first quarter of 2024, the Company repaid 9 HUD mortgages totaling $41.6 million from invested cash balances.

BALANCE SHEET AND LIQUIDITY

As of March 31, 2024, the Company had $5.1 billion of outstanding indebtedness with a weighted-average annual interest rate of 4.4%. The Company’s indebtedness consisted of an aggregate principal amount of $4.6 billion of senior unsecured notes, $478.5 million of unsecured term loans, $19.8 million of secured debt and $20.2 million of borrowings outstanding under its unsecured revolving credit facility. As of March 31, 2024, total cash and cash equivalents were $361.8 million, and the Company had $1.4 billion of undrawn capacity under its unsecured revolving credit facility.

$400 Million Note Repayment – On April 1, 2024, the Company repaid its $400.0 million 4.950% senior notes that matured on April 1, 2024, from invested cash balances and borrowings under its unsecured revolving credit facility.

DIVIDENDS

On April 18, 2024, the Board of Directors declared a quarterly cash dividend of $0.67 per share, to be paid May 15, 2024, to common stockholders of record as of the close of business on April 30, 2024.

2024 GUIDANCE AFFIRMED

The Company affirmed that it expects its 2024 Adjusted FFO to be between $2.70 and $2.80 per diluted share.

The Company's guidance is based on several assumptions including those noted above, which are subject to change and many of which are outside the Company’s control. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the timing of collection of rental obligations from operators on a cash basis, the timing and completion of acquisitions, divestitures, restructurings and capital and financing transactions may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results. The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.

The Company does not provide a reconciliation for its Adjusted FFO guidance to GAAP net income because it is unable to determine meaningful or accurate estimates of reconciling items without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and/or amounts of various items that would impact future net income. This includes, but is not limited to, changes in the provision for credit losses, real estate impairments, acquisition, merger and transition related costs, straight-line write-offs, gain/loss on assets sold, etc. In particular, the Company is unable to predict with reasonable certainty the amount of the change in the provision for credit losses in future periods, which is often a significant reconciling adjustment.

ADDITIONAL INFORMATION

Additional information regarding the Company can be found in its First Quarter 2024 Financial Supplemental posted under “Financial Info” in the Investors section of Omega’s website. The information contained on, or that may be accessed through, Omega’s website, including the information contained in the aforementioned supplemental, is not incorporated by any reference into, and is not part of, this document.

CONFERENCE CALL

The Company will be conducting a conference call on Friday, May 3, 2024, at 10 a.m. Eastern time to review the Company’s 2024 first quarter results and current developments. Analysts and investors within the U.S. interested in participating are invited to call (877) 407-9124. The international toll-free dial-in number is (201) 689-8584. Ask the operator to be connected to the “Omega Healthcare’s First Quarter 2024 Earnings Call.”

To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the “Omega Healthcare Investors, Inc. 1Q Earnings Call” hyper-link on the “Investors” page of Omega’s website. Webcast replays of the call will be available on Omega’s website for a minimum of two weeks following the call. Additionally, a copy of the earnings release will be available in the “Financial Info” section and “SEC Filings” section on the “Investors” page of Omega’s website.

* * * * * *

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Forward-Looking Statements and Cautionary Language

This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega’s or its tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations.

Omega’s actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of Omega’s properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) the long-term impacts of the Novel coronavirus (“COVID-19”) pandemic on our business and the business of our operators, including the levels of staffing shortages, increased costs and decreased occupancy experienced by operators of skilled nursing facilities (“SNFs”) and assisted living facilities (“ALFs”) arising from the pandemic, the ability of our operators to comply with infection control and vaccine protocols and to manage facility infection rates or future infectious diseases, and the sufficiency of government support and reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including federal minimum staffing requirements for SNFs that may further exacerbate labor and occupancy challenges for Omega’s operators; (iv) the ability of any of Omega’s operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega’s mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations, and other costs and uncertainties associated with operator bankruptcies; (v) Omega’s ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and ALF markets or local real estate conditions; (vi) the availability and cost of capital to Omega; (vii) changes in Omega’s credit ratings and the ratings of its debt securities; (viii) competition in the financing of healthcare facilities; (ix) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (x) changes in the financial position of Omega’s operators; (xi) the effect of economic and market conditions generally, and particularly in the healthcare industry; (xii) changes in interest rates and the impact of inflation; (xiii) the timing, amount and yield of any additional investments; (xiv) changes in tax laws and regulations affecting REITs; (xv) Omega’s ability to maintain its status as a REIT; (xvi) the effect of other factors affecting our business or the businesses of Omega’s operators that are beyond Omega’s or operators’ control, including natural disasters, other health crises or pandemics and governmental action, particularly in the healthcare industry, and (xvii) other factors identified in Omega’s filings with the Securities and Exchange Commission. Statements regarding future events and developments and Omega’s future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward looking statements.

We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

2024

 

2023

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

Real estate assets

 

 

 

 

 

 

Buildings and improvements

 

$

6,866,358

 

$

6,879,034

Land

 

 

865,028

 

 

867,486

Furniture and equipment

 

 

467,178

 

 

467,393

Construction in progress

 

 

162,269

 

 

138,410

Total real estate assets

 

 

8,360,833

 

 

8,352,323

Less accumulated depreciation

 

 

(2,526,536)

 

 

(2,464,227)

Real estate assets – net

 

 

5,834,297

 

 

5,888,096

Investments in direct financing leases – net

 

 

8,873

 

 

8,716

Real estate loans receivable – net

 

 

1,246,528

 

 

1,212,162

Investments in unconsolidated joint ventures

 

 

185,937

 

 

188,409

Assets held for sale

 

 

81,546

 

 

81,546

Total real estate investments

 

 

7,357,181

 

 

7,378,929

Non-real estate loans receivable – net

 

 

269,342

 

 

275,615

Total investments

 

 

7,626,523

 

 

7,654,544

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

361,773

 

 

442,810

Restricted cash

 

 

1,253

 

 

1,920

Contractual receivables – net

 

 

10,973

 

 

11,888

Other receivables and lease inducements

 

 

223,281

 

 

214,657

Goodwill

 

 

643,778

 

 

643,897

Other assets

 

 

144,267

 

 

147,686

Total assets

 

$

9,011,848

 

$

9,117,402

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

Revolving credit facility

 

$

20,213

 

$

20,397

Secured borrowings

 

 

20,145

 

 

61,963

Senior notes and other unsecured borrowings – net

 

 

4,987,794

 

 

4,984,956

Accrued expenses and other liabilities

 

 

283,103

 

 

287,795

Total liabilities

 

 

5,311,255

 

 

5,355,111

 

 

 

 

 

 

 

Preferred stock $1.00 par value authorized – 20,000 shares, issued and outstanding – none

 

 

—

 

 

—

Common stock $.10 par value authorized – 350,000 shares, issued and outstanding – 246,377 shares as of March 31, 2024 and 245,282 shares as of December 31, 2023

 

 

24,637

 

 

24,528

Additional paid-in capital

 

 

6,705,333

 

 

6,671,198

Cumulative net earnings

 

 

3,747,942

 

 

3,680,581

Cumulative dividends paid

 

 

(6,995,876)

 

 

(6,831,061)

Accumulated other comprehensive income

 

 

31,852

 

 

29,338

Total stockholders’ equity

 

 

3,513,888

 

 

3,574,584

Noncontrolling interest

 

 

186,705

 

 

187,707

Total equity

 

 

3,700,593

 

 

3,762,291

Total liabilities and equity

 

$

9,011,848

 

$

9,117,402

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

2023

 

Revenues

 

 

 

 

 

 

 

Rental income

 

$

203,204

 

$

185,355

 

Real estate tax and ground lease income

 

 

3,717

 

 

3,976

 

Real estate loans interest income

 

 

28,739

 

 

23,397

 

Non-real estate loans interest income

 

 

7,097

 

 

5,023

 

Miscellaneous income

 

 

542

 

 

451

 

Total revenues

 

 

243,299

 

 

218,202

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Depreciation and amortization

 

 

74,557

 

 

81,192

 

General and administrative

 

 

11,794

 

 

11,414

 

Real estate tax and ground lease expense

 

 

4,309

 

 

4,365

 

Stock-based compensation expense

 

 

9,227

 

 

8,744

 

Acquisition, merger and transition related costs

 

 

2,603

 

 

639

 

Impairment on real estate properties

 

 

5,292

 

 

38,988

 

Provision (recovery) for credit losses

 

 

8,470

 

 

(4,057)

 

Interest expense

 

 

54,144

 

 

55,293

 

Interest – amortization of deferred financing costs

 

 

3,676

 

 

3,253

 

Total expenses

 

 

174,072

 

 

199,831

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

Other income – net

 

 

5,276

 

 

2,720

 

Loss on debt extinguishment

 

 

(1,283)

 

 

(6)

 

(Loss) gain on assets sold – net

 

 

(1,391)

 

 

13,637

 

Total other income

 

 

2,602

 

 

16,351

 

 

 

 

 

 

 

 

 

Income before income tax (expense) benefit and income from unconsolidated joint ventures

 

 

71,829

 

 

34,722

 

Income tax (expense) benefit

 

 

(2,581)

 

 

1,292

 

Income from unconsolidated joint ventures

 

 

98

 

 

831

 

Net income

 

 

69,346

 

 

36,845

 

Net income attributable to noncontrolling interest

 

 

(1,985)

 

 

(903)

 

Net income available to common stockholders

 

$

67,361

 

$

35,942

 

 

 

 

 

 

 

 

 

Earnings per common share available to common stockholders:

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

0.27

 

$

0.15

 

Diluted:

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

0.27

 

$

0.15

 

Dividends declared per common share

 

$

0.67

 

$

0.67

 

OMEGA HEALTHCARE INVESTORS, INC.

Nareit FFO, Adjusted FFO and FAD Reconciliation

Unaudited

(in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31,

 

 

2024

 

2023

 

 

 

 

 

 

 

Net income (1)

 

$

69,346

 

$

36,845

Add back loss (deduct gain) from real estate dispositions

 

 

1,391

 

 

(13,637)

Sub-total

 

 

70,737

 

 

23,208

Elimination of non-cash items included in net income:

 

 

 

 

 

 

Depreciation and amortization

 

 

74,557

 

 

81,192

Depreciation - unconsolidated joint ventures

 

 

2,536

 

 

2,684

Add back provision for impairments on real estate properties

 

 

5,292

 

 

38,988

Nareit funds from operations (“Nareit FFO”)

 

$

153,122

 

$

146,072

 

 

 

 

 

 

 

Weighted-average common shares outstanding, basic

 

 

246,071

 

 

234,954

Restricted stock and PRSUs

 

 

3,756

 

 

1,384

Omega OP Units

 

 

7,437

 

 

6,850

Weighted-average common shares outstanding, diluted

 

 

257,264

 

 

243,188

 

 

 

 

 

 

 

Nareit funds from operations available per share

 

$

0.60

 

$

0.60

 

 

 

 

 

 

 

Adjustments to calculate adjusted funds from operations

 

 

 

 

 

 

Nareit FFO

 

$

153,122

 

$

146,072

Add back:

 

 

 

 

 

 

Provision (recovery) for credit losses

 

 

9,640

 

 

(1,441)

Stock-based compensation expense

 

 

9,227

 

 

8,744

Acquisition, merger and transition related costs

 

 

2,603

 

 

639

Loss on debt extinguishment

 

 

1,283

 

 

6

Non-recognized cash interest

 

 

300

 

 

2,096

Non-recurring expense

 

 

232

 

 

—

Uncollectible accounts receivable (2)

 

 

—

 

 

12,500

Deduct:

 

 

 

 

 

 

Non-recurring revenue

 

 

(289)

 

 

(8,815)

Adjusted funds from operations (“AFFO”) (1)(3)

 

$

176,118

 

$

159,801

 

 

 

 

 

 

 

Adjustments to calculate funds available for distribution

 

 

 

 

 

 

Non-cash expense

 

$

3,197

 

$

2,224

Capitalized interest

 

 

(1,518)

 

 

(908)

Non-cash revenue

 

 

(9,880)

 

 

(14,095)

Funds available for distribution (“FAD”) (1)(3)

 

$

167,917

 

$

147,022

(1)

The three months ended March 31, 2024 and 2023 include the application of $0.5 million and $5.2 million, respectively, of security deposits (letters of credit and cash deposits) in revenue.

(2)

The three months ended March 31, 2023 includes a $12.5 million lease inducement write-off recorded as a reduction to rental income related to the Maplewood option termination fee. All other amounts represent straight-line accounts receivable write-offs also recorded as a reduction to rental income.

(3)

Adjusted funds from operations per share and funds available for distribution per share can be calculated using weighted-average common shares outstanding, diluted, as shown above.

Nareit Funds From Operations (“Nareit FFO”), Adjusted FFO and Funds Available for Distribution (“FAD”) are non-GAAP financial measures. As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The Company calculates and reports Nareit FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts (“Nareit”), and consequently, Nareit FFO is defined as net income (computed in accordance with GAAP), adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization and impairments on real estate assets, and after adjustments for unconsolidated partnerships and joint ventures and changes in the fair value of warrants. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect funds from operations on the same basis. Revenue recognized based on the application of security deposits and letters of credit or based on the ability to offset against other financial instruments is included within Nareit FFO. The Company believes that Nareit FFO, Adjusted FFO and FAD are important supplemental measures of its operating performance. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. The term funds from operations was designed by the real estate industry to address this issue. Funds from operations described herein is not necessarily comparable to funds from operations of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.

Adjusted FFO is calculated as Nareit FFO excluding the impact of non-cash stock-based compensation and certain revenue and expense items (e.g., acquisition, merger and transition related costs, write-off of straight-line accounts receivable, recoveries and provisions for credit losses (excluding certain cash recoveries on impaired loans), cash interest received but not included in revenue, non-recognized cash interest, severance, legal reserve expenses, etc.). FAD is calculated as Adjusted FFO less non-cash expense, such as the amortization of deferred financing costs and non-cash revenue, such as straight-line rent. The Company believes these measures provide an enhanced measure of the operating performance of the Company’s core portfolio as a REIT. The Company’s computation of Adjusted FFO and FAD may not be comparable to the Nareit definition of funds from operations or to similar measures reported by other REITs, but the Company believes that they are appropriate measures for this Company.

The Company uses these non-GAAP measures among the criteria to measure the operating performance of its business. The Company also uses FAD among the performance metrics for performance-based compensation of officers. The Company further believes that by excluding the effect of depreciation, amortization, impairments on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs, and which may be of limited relevance in evaluating current performance, funds from operations can facilitate comparisons of operating performance between periods. The Company offers these measures to assist the users of its financial statements in analyzing its operating performance. These non-GAAP measures are not measures of financial performance under GAAP and should not be considered as measures of liquidity or cash flow, alternatives to net income or indicators of any other performance measure determined in accordance with GAAP. Investors and potential investors in the Company’s securities should not rely on these non-GAAP measures as substitutes for any GAAP measure, including net income.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502021764/en/

Matthew Gourmand, SVP, Corporate Strategy & Investor Relations or Bob Stephenson, CFO at (410) 427-1700